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A B S T R A C T
open sinus lift is used to augment the maxillary sinus prior to implant Placement in patients with sinus pneu-
matization due to early extraction of upper molars Where the remaining available bone length is from zero to
6mm which will not accommodate for implant placement and not sufficient for implant initial stability so we
will need to do Sinus lift and augmentation of the sinus with various bone grafts either (alloplast, allograft,
Autogenous). Search is conducted electronically on line in pub med & Cochrane and manual Search was also
done from 2007 to 2018 the articles included assisting &evaluating various types of bone substitute used in open
sinus lift surgeries.197 papers are identified through data base searching 37 Additional records identified
through manual search, after duplication removal the remaining papers are 187,187 paper were reviewed&152
were excluded by title &abstract, 35 article were reviewed as full text, 27 articles were excluded by reason, 8
articles were included in this study, Eight included articles have revealed new bone formation with percentage
ranges from 48%as the highest percentage&16.4 as the lowest percentage, residual material ranges from 6.3%to
34.8% which differs according to type of bone graft used, histological evaluation is performed in 7 articles in
addition to radiological evaluation only one article used radiographic evaluation only This systematic review
supported the fact that bone substitute act as a scaffold for new bone formation with different percentages
according to type of bone substitute used.
1. Introduction
After extraction of teeth in posterior maxilla alveolar bone resorp-
tion takes place as well as maxillary sinus pneumatization results in
bone loss. Long term survival and success of dental implant requires
primary stability and appropriate bone volume [1]. It was clearly de-
monstrated that implants placed in poor bone quality have higher
failure rates than implant placed in higher bone quality [2,3]. Implants
placed in posterior region of maxilla showed the lowest success. The
poorest bone density exists in posterior region of the maxilla therefore it
is associated with the highest failure rates [3,4].Misch has revealed that
bone density of the implant bed is an important factor in determining
the treatment plan; implant design, surgical approach, healing time and
initial progressive bone loading during prosthetic reconstruction.
He classified bone density: D1: Dense cortical bone. D2:Thick dense
to porous cortical bone on the crest and coarse trabecular bone within.
D3: Thin porous cortical bone on the crest and fine trabecular bone
within. D4: Fine trabecular bone. D5: Immature, non-mineralized bone
[5,6].Bone quality is classified into 4 categories according to lecholm
and zarb [7] Type I: composed of homogenous compact bone. Type II:
composed of thick layer of compact bone surrounding a core of dense
trabecular bone. Type III: composed of thin layer of cortical bone sur-
rounding dense trabecular bone. Type IV: composed of a thin layer of
cortical bone surrounding a low density core of trabecular bone. Gaffin
and Berman reported 55% of all implant failure occurred in type IV
bone [8]Increasing bone volume in posterior maxilla and bone quality
has been achieved by combining various procedures and materials [9].
Elevation and augmentation of the maxillary sinus can increase the
bone height in the posterior area of the maxilla [10].
At the Consensus Conference on Maxillary Sinus Elevation in 1996
[11] the members made the following recommendations which depend
on the residual bone height (RBH):
• Category A (RBH≥ 10mm): classic implant procedure
• Category B (RBH≥ 7–9mm): osteotome technique with simulta-
neous placement of implants
• Category C (RBH≥ 4–6mm): maxillary sinus elevation with lateral
access and bone graft and immediate or deferred placement of
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implants
• Category D (RBH≥ 1–3mm): maxillary sinus elevation with lateral
access and bone graft and deferred placement of implants
During the maxillary sinus floor elevation procedure, the space
created between the residual maxillary ridge and the elevated
Schneiderian membrane is usually filled with grafting material ([12]
[13]). In this way, a bone fraction is created that may allow for reliable
implant placement, either simultaneously with the elevation procedure
when the residual ridge allows for primary implant stability or as a
second stage after healing of the grafted site [14].
Bone grafting materials are generally classified as autografts, allo-
grafts, xenografts and alloplasts. Out of these, autografts harvested from
the patient's own body (chin, hip, ribs etc) are regarded “gold standard”
[15,16]. Because of the lack of antigenicity of the graft material os-
teoconduction&osteoinduction. Allografts are transplants from a ge-
netically non identical individual of same species which are “con-
verted” to self by the host [16,17].
Xenografts are transplants from one species to another. Bovine de-
rived bone is a good example of xenograft. Alloplasts are synthetic
chemically derived bone substitute. Most often this material is a form of
calcium phosphate. Although autograft material is currently the mate-
rial of choice, there are limitations associated with its use, including
donor site morbidity, limited donor bone supply, anatomical and
structural problems, Band elevated levels of resorption during healing
[18].
The use of allografts has the disadvantage of eliciting an im-
munological response due to genetic differences and the risk of indu-
cing transmissible diseases [18,19]. Calcium phosphate ceramics and
bioactive glasses were introduced more than 30 years ago as bone
substitutes. These materials are considered bioactive because they bond
to bone and enhance bone tissue formation.
The forms of calcium phosphate ceramics most widely used are
tricalcium phosphate (B-TCP)and hydroxyapatite (HA). These materials
have a similar structure to the mineral phase of bone and have been
shown to be osteoconductive, i.e., enhance bone cells growth and direct
bone deposition on their surfaces. The availability of HA and TCP in
porous shapes has encouraged many investigators to evaluate the
ability of these biomaterials to serve as tissue engineering scaffolds for
cell and drug delivery.
However, there were setbacks. Hydroxyapatite is known to exhibit
limited osteoconduction and has a slow rate of degradation in physio-
logical solutions because of its chemical stability [20,21]. On the other
hand, B -TCP is plagued by an unpredictable, fast rate of dissolution
that may lead to an immunological response [22].
Bioactive glass (BG), which contains (45 wt %) of silica in addition
to calcium and phosphorous, is known to have the most stimulatory
effect on bone cell function [23,24].
Unfortunately, there is a limited opportunity to synthesize a porous
BG and improve its mechanical and physicochemical properties without
decrements in bioactivity.
Recently, a novel porous silica–calcium phosphate nanocomposite
(SCPC) has been proposed as a candidate for bone tissue engineering
scaffold. The new resorbable porous bioactive silica-calcium phosphate
composite has the ability to absorb high quantities of serum protein and
stimulate rapid bone generation. The high porosity of the SCPC en-
hanced cell colonization and bone formation on and within the graft
material. The high rate of silica dissolution from SCPC promoted rapid
bone regeneration and graft material resorption. Thermal treatment of
the SCPC induced ion substitution and formation of solid solutions at
significantly low temperature. These ultra structural modifications fa-
cilitated protein adsorption and controlled SCPC solubility [25,26].
It has been demonstrated that SCPC has a superior bone re-
generative capacity and resorbability when compared to HA and
bioactive glass.
The nanoporous structure, superior bioactivity, controlled
dissolution kinetics, and strong stimulatory effect on osteoblast differ-
entiation suggest wide applications of SCPC in the field of bone tissue
reconstruction in maxillofacial surgeries.
The current study reviews the literature of application various types
of bone substitute used for augmentation of the maxillary sinus by
searching on Electronic Search engines are Pub Med and Cochrane.
Manual search was done in the libraries of the Faculty of Oral & Dental
Medicine, Cairo University; Faculty of Oral and Dental Medicine, Al-
Azhar University; and the Faculty of Oral & Dental Medicine, Future
University in Egypt.
2. Materials & methods
Publications on the subject were searched up to.2018on electronic
database (Cochrane & pub med) the keywords used are
1 "Sinus floor augmentation" [Mesh]
2 (((Calcium phosphate ceramics))) or ((Bioceramics)) and (Bone
Augmentation)
3 (((Bone augmentation))) and ((Hyd\roxyapatite))
4 (((Hydroxyapatite))) and ("Sinus floor augmentation") Mesh
• The Manual search was done in the libraries of the Faculty of Oral
& Dental Medicine, Cairo University; Faculty of Oral and Dental
Medicine, Al-Azhar University; and the Faculty of Oral & Dental
Medicine, Future University in Egypt.
2.1. Study selection
The PRISMA flow diagram in (Fig. 1) presents an overview of the
selection process. The titles of identified reports were initially screened.
The abstract was assessed when the title indicated that the study ful-
filled the inclusion criteria. A full-text analysis was performed when the
abstract was unavailable or when the abstract indicated that the in-
clusion criteria were fulfilled. The references of the identified papers
were cross-checked for unidentified articles.
Screening process showed in the prisma chart: two independent
reviewers screened187papers retrieved from electronic and manual
search for possible inclusion in the review. 151 articles are excluded on
the base of title and abstract. 27 articles are excluded on the base of
exclusion criteria.8 articles are included according to the inclusion
criteria.
2.2. Study eligibility
• Inclusion criteria: randomized control trial or retrospective studies
on open sinus lift and bone grafting. Adult, Medically Free, Sinus
approximation 2–6mm and In English
• The following exclusion criteria were applied: Pediatric, Medically
Compromised, Invitro, Autogenous Graft, metanalysis.
3. Results
Initial search reviewed 197 paper from electronic search (pup med
& Cochrane)&37 papers from manual search, 187 paper is present after
filtration &duplication removal, 152 paper were excluded from title &
abstract, remaining 35 articles were reviewed as full text articles, 27
paper were excluded according to the exclusion criteria, 8 articles were
included in the study according to the inclusion criteria(Fig. 1) (Tables
1 and 2).
3.1. Reviewing & data extraction
Two independent researchers reviewed the selected 8 full text ar-
ticles. 139 patients were included in all reviewed articles. The articles
were analyzed as per overall study design and data mining of the ar-
ticles included the collection of the following data: number of patients
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in each article, age, gender, amount of residual alveolar bone
(< 7mm), type of graft used, time of implant placement and core bone
biopsy retrieval and the amount of bone gain (as percentage or in
millimeters).
Histological evaluation of newly formed bone showed 26.4% newly
formed bone, 27.3% residual graft material, and 46.3% bone marrow in
Kolerman et al. (2012) article [27]; while Stavropoulos A. et al. (2011)
had an average of 28–31.8% newly formed bone, 6.3–16.5% residual
graft, and the new bone was primarily woven and characterized by
slender trabeculae and narrow osteoid zones, and in many instances
bone was in contact with residual biomaterial particles [28]. On the
other hand, Martinez et al. (2010) documented average newly formed
bone of 35%, and residual graft of 32.6–34.8 ± 6.2–10.5%. Englrbert
A et al. (2013) demonstrated 19–24% bone gain with a 19% residual
bone [31]. Contrary to the reported high regenerated bone levels of
48% reported by Canullo L et al. (2009) at 6 months and 28% residual
graft and 24% bone marrow. Histomorphometric analysis of different
bone grafts by Susanna Annibali et al. (2014) reported newly formed
bone ranging from as low as: 16.4% using mineralized solvent-dehy-
drated bone allograft (MSDBA) and as high as: 21.9% using equine bone
(EB) [33]. On contrary, were the recent results of Claudio Stacchi et al.
(2017) that demonstrated 34.9 ± 15% (NHA) 38.5 ± 17% (ABB) of
vital bone and 20.6 ± 13% (NHA).± 12% (ABB) of residual graft
material & an overall 12 months loading success rate of 96.4% [34].
Radiographic studies as that of Jae-Kook Cha et al. (2011) reported
sinus floor heights of a mean3to4mm42 months with an insignificant
loss of 0.83 ± 0.38mm [29].while Kolerman et al. (2012)augmented
sinus floor of remaining alveolar height of 5mm up to18mm he used
C.T scan to evaluate height in mm & area in mm2 [27] englrbert A et al.,
2013 reported increase in bone height ranges from 7.2 to 7.8 mm when
sinus floor of less than 7mm he used panoramic x ray for evaluation of
bone height gain [31].
4. Discussion
Bone resorption following tooth extraction or due to advanced
periodontal disease, and/or pneumatization of the maxillary sinus may
result in insufficient bone in horizontal and/or more frequently, vertical
dimension for the placement of dental implants in the posterior maxilla.
Augmentation of the maxillary sinus floor (or sinus lift) with bone grafts
and/or substitutes is nowadays a standard treatment approach for re-
establishing an adequate bone volume in the posterior maxilla. Bone
resorption following tooth extraction or due to advanced periodontal
disease, and/or pneumatization of the maxillary sinus may result in
insufficient bone in horizontal and/or more frequently, vertical di-
mension for the placement of dental implants in the posterior maxilla.
Prosthodontic rehabilitation through dental endosseous implants in
the area of the posterior maxilla often fails due to an insufficient bone
supply. To improve bone volume to support dental implants, tissue
formation is commonly enhanced by autologous bone grafting, often
combined with synthetic, resorbable materials.
In the present systematic review 8 articles were included according
to the inclusion criteria, these articles were reviewed at which 139
patient were included in this review, these patients have open sinus lift
procedure, with bone graft to augment the sinus followed by implant
placement in a second surgery after a period from 3 to 6 months,
radiological analysis were performed using C.B.C.T or C.T scan or pa-
norama, during implant placement core bone biopsy were retrieved &
analyzed either for histological and histomorphometric analysis, the
sinuses for the 139 patients were augmented with various grafting
materials.
7 articles have histological results in percentages for the newly
formed bone &the amount of residual graft material, the highest level of
bone gain was reported of 48% reported by Canullo L et al. (2009) after
6 months of grafting who used nanocrystalline hydroxyapatite silica gel
[32] & the lowest level of bone gain was reported Susanna Annibali
et al. (2014) reported newly formed bone of 16.4% using (MSDBA)
Fig. 1. The prisma flow diagram.
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mineralized solvent dehydrated bone allograft [33], while the lowest
amount of residual material was reported in Stavropoulos A. et al.
(2011) was 6.3% residual graft in the recombinant human growth
factor and differentiation factor-5-coated tricalcium phosphate (rhGDF-
5/b-TCP)/4-month group [28] & the highest amount of residual ma-
terial 34.8 ± 10.5.% for anorganic bovine-bone derived (ABB) re-
ported by Martinez et al. (2010) [30].
So it is clear that the rate of new bone formation & the amount of
residual material depends on the type of material used& its rate of re-
sorption as the technique of sinus lift is similar in the patients included
in the 7 articles & methods of histological evaluation is almost the same.
On the other hand radiographic evaluation was conducted in 2
articles beside the histological evaluation Kolerman et al. (2012) &
(englrbert A et al., 2013) measured increase in height in term of mm.
The increase in height ranges from 7 up to 18mm [27,31].
While only one article used the radiographic evaluation without
histological evaluation (Jae-Kook Cha et al., 2011) this study use
Osteon, as a bone graft material, and to assess the height of the grafted
material through radiographic evaluation. In this study the author used
panoramic and intraoral films for evaluation of the rate of resorption of
the grafted material this radiograph is a two dimensions tool which is
not accurate to determine the rate of bone changes, the three dimension
C.T scan is the recommended method for evaluation of bone changes
[29].
Table 1
List of excluded articles after reviewing.
Authors Article name Reason for exclusion
1 Walter C, Mang WL Daculsi G et al. Artificial bone (tricalcium phosphate) in facial surgery (author's transl). 1 Artificial bone
Daculsi G, Bouler JM, LeGeros RZ 1 Adaptive crystal formation in normal and pathological calcifications in
synthetic calcium phosphate and related biomaterials..
2 Synthetic calcium
phosphate
2 Kim SM, Park JW, Suh JY, Sohn DS, Lee JM 2 Bone-added osteotome technique versus lateral approach for sinus floor
elevation: a comparative radiographic study..
3 Bone marrow
concentrate and bovine
bone mineral
3 Cortes AR, Cortes DN, Arita ES Cone beam computed tomographic evaluation of a maxillary alveolar ridge
reconstruction with iliac crest graft and implants.
2 Sinus lift techniques
4 Arasawa M, Oda Y, Kobayashi T, Uoshima K, Nishiyama H,
Hoshina H, Saito C
Evaluation of bone volume changes after sinus floor augmentation with
autogenous bone grafts.
Autogenous Graft, ridge
reconstruction
5 Nery EB, Pflughoeft FA, Lynch KL, Rooney GE. Functional loading of bioceramic augmented alveolar ridge–a pilot study. Autogenous Graft
6 Nery EB, Pflughoeft FA, Lynch KL, Rooney GE. Functional loading of bioceramic augmented alveolar ridge–a pilot study. Autogenous Graft
7 Degidi M, Piattelli A, Perrotti V, Iezzi G. Histologic and histomorphometric evaluation of an implant retrieved 8
years after insertion in a sinus augmented with anorganic bovine bone and
anorganic bovine matrix associated with a cell-binding peptide: a case
report.
augmented alveolar ridge
8 Cricchio G, Palma VC, Faria PE, de Olivera JA, Lundgren S,
Sennerby L, Salata LA
Histological outcomes on the development of new space-making devices for
maxillary sinus floor augmentation..
Different bone graft
9 Kolerman R, Samorodnitzky-Naveh GR, Barnea E, Tal H. 3 Histomorphometric analysis of newly formed bone after bilateral
maxillary sinus augmentation using two different osteoconductive
materials and internal collagen membrane.
Different bone graft
10 Schmelzeisen R, Gutwald R, Oshima T, Nagursky H, Vogeler M,
Sauerbier S
Making bone II: maxillary sinus augmentation with mononuclear cells–case
report with a new clinical method.
1 Different bone graft
11 Jensen T, Schou S, Stavropoulos A, Terheyden H, Holmstrup P 1 Maxillarysinusflooraugmentation with Bio-Oss or Bio-Oss mixed with
autogenous bone as graft in animals: a systematic review.
2 Different bone graft
12 Özkan Y, Akoğlu B, Kulak-Özkan Y Maxillary sinus floor augmentation using bovine bone grafts with
simultaneous implant placement: a 5-year prospective follow-up study.
1 Autogenous Graft
13 Lee DZ, Chen ST, Darby IB. 4 Maxillary sinus floor elevation and grafting with deproteinized bovine
bone mineral: a clinical and histomorphometric study.
Different bone graft
14 Antonaya-Mira R, Barona-Dorado C, Martínez-Rodríguez N,
Cáceres-Madroño E, Martínez-González JM
Meta-analysis of the increase in height in maxillary sinus elevations with
osteotome.
1 Different bone graft
15 Cabezas-Mojón J, Barona-Dorado C, Gómez-Moreno G,
Fernández-Cáliz F, Martínez-González JM
5 Meta-analyticstudy of implant survival following sinus augmentation. Sinuslift without bone graft
16 Esposito M, Cannizzaro G, Soardi E, Pistilli R, Piattelli M,
Corvino V, Felice P
Posterior atrophic jaws rehabilitated with prostheses supported by 6mm-
long, 4mm-wide implants or by longer implants in augmented bone.
Preliminary results from a pilot randomized controlled trial.
sinus lift without bone graft
.17 Hart KL, Bowles D 6 Reconstruction of alveolar defects using titanium-reinforced porous
polyethylene as a containment device for recombinant human bone
morphogenetic protein.
Sinuslift without bone graft
18.Perelli M, Abundo R, Corrente G, Saccone C 1 Short (5 and 7mm long) porous implants in the posterior atrophic
maxilla: a 5-year report of a prospective single-cohort study.
Sinuslift without bone graft
19 Butz F, Bächle M, Ofer M, Marquardt K, Kohal RJ 1 Sinus augmentation with bovine hydroxyapatite/synthetic peptide in a
sodium hyaluronate carrier (PepGen P-15 Putty): a clinical investigation
of different healing times.
Without sinus lift
21 Schuller-Götzburg P, Entacher K, Petutschnigg A, Pomwenger W,
Watzinger F
7 Sinus elevation with a cortical bone graft block: a patient-specific three-
dimensional finite element study.
Autogenous bone graft
22.Petruzzi M, Ceccarelli R, Testori T, Grassi FR Sinus floor augmentation with a hydropneumatic technique: a retrospective
study in 40 patients
1 Autogenous bone graft
23 Sauerbier S, Rickert D, Gutwald R, Nagursky H, Oshima T, Xavier
SP, Christmann J, Kurz P, Menne D, Vissink A, Raghoebar G,
Schmelzeisen R, Wagner W, Koch FP.
8 Bone marrow concentrate and bovine bone mineral for sinus floor
augmentation: a controlled, randomized, single-blinded clinical and
histological trial–per-protocol analysis.
Different bone graft
24 Szivek JA, Anderson PL, Dishongh TJ, DeYoung DW. 1 Evaluation of factors affecting bonding rate of calcium phosphate
ceramic coatings for in vivo strain gauge attachment.
Different bone graft
25 Sijeet singh, hemant gupta, deepka kumar Immediate implant placement along with bone graft and delayed implant
placement in grafted socket:comparative study
No sinus lift
26 J. Mehta, A. El-Ghannam, C. Q. Ning. Cyclosilicate nanocomposite: A novel resorbable bioactive tissue
engineering scaffold for BMP and bone-marrow cell delivery
Invitro
27 AEl-Ghannam,LarryCunningham, David Pienkowski. Bone Engineering of the Rabbit Ulna experimental
A.K. Abo zekry et al. Future Dental Journal 4 (2018) 135–140
138 138
Future Dental Journal of Egypt, Vol. 4 [2018], Iss. 2, Art. 6
https://digitalcommons.aaru.edu.jo/fdj/vol4/iss2/6
Ta
bl
e
2
Li
st
of
in
cl
ud
ed
ar
ti
cl
es
.
A
rt
ic
le
Sa
m
pl
e
si
ze
G
en
de
r
A
ge
R
es
id
ua
l
al
ve
ol
ar
bo
ne
M
at
er
ia
l
us
ed
&
pa
rt
ic
le
si
ze
Ti
m
e
of
im
pl
an
t
pl
ac
em
en
t
O
ut
co
m
e
M
ea
su
re
s
(b
on
e
ga
in
)
D
ev
ic
e,
U
ni
t
of
m
ea
su
re
St
ud
y
de
si
gn
M
F
M
m
%
C
T
A
liz
ar
in
pa
K
ol
er
m
an
et
al
.
[2
7]
12
5
7
42
–8
0
ye
ar
s
5
m
m
H
A
:_-
TC
P
0.
5–
1
m
m
9
m
on
th
s
6–
18
m
m
26
.4
%
ne
w
ly
fo
rm
ed
bo
ne
27
.3
%
re
si
du
al
gr
af
t
H
ei
gh
t,
W
id
th
(i
n
m
m
)
A
re
a
(i
n
m
m
2)
Im
ag
e
J
so
ft
w
ar
e
Si
gn
al
in
te
ns
it
y
R
.C
.T
St
av
ro
po
ul
os
A
et
al
.[
28
]
31
16
15
41
–6
5.
9
ye
ar
s
5
m
m
rh
G
D
F-
5/
b-
TC
P.
β-
TC
P/
A
B.
3–
4
m
on
th
s
31
.4
%
in
th
e
rh
G
D
F-
5/
b-
TC
P.
28
%
in
th
e
rh
G
D
F-
5/
b-
TC
P.
31
.8
%
in
th
e
b-
TC
P/
A
B
gr
ou
p.
Th
e
pr
op
or
ti
on
of
re
m
ai
ni
ng
b-
TC
P
av
er
ag
ed
12
.6
%
in
th
e
rh
G
D
F-
5/
b-
TC
P/
3-
m
on
th
gr
ou
p,
6.
6%
in
th
e
rh
G
D
F-
5/
b-
TC
P/
4-
m
on
th
gr
ou
p,
an
d
16
.5
%
in
th
e
b-
TC
P/
A
B
gr
ou
p.
A
liz
ar
in
re
d
st
ai
n
us
in
g
Im
ag
e
J
so
ft
w
ar
e
Si
gn
al
In
te
ns
it
y
R
.C
.T
Ja
e-
K
oo
k
C
ha
et
al
.[
29
]
20
–
–
4-
3
m
m
O
st
eo
n
0.
5–
1
m
m
1–
2
m
m
6
m
on
th
s
S0
.8
1
±
0.
43
m
m
L0
.8
5
±
0.
33
m
m
m
m
R
.C
.T
M
ar
ti
ne
za
et
al
.
[3
0]
16
-
38
–6
7y
3.
8
m
m
A
BB
,T
C
P
1.
6
±
0.
4
cm
2
8
m
on
th
s
35
%
of
ne
w
bo
ne
fo
rm
ed
fo
r
bo
th
gr
ou
ps
re
m
ai
ni
ng
pr
es
en
ce
of
TC
P
pa
rt
ic
le
s
w
as
32
.6
±
6.
2%
an
d
34
.8
±
10
.5
.%
fo
r
A
PP
A
liz
ar
in
re
d
st
ai
n
us
in
g
Im
ag
e
J
so
ft
w
ar
e
Si
gn
al
In
te
ns
it
y
R
.C
.T
en
gl
rb
er
t
A
et
al
.
[3
1]
12
-
36
–7
3y
≤
7
m
m
βT
C
P
60
%
0.
7–
1.
4
m
m
,
R
es
or
ba
bl
ec
ol
la
ge
no
us
m
em
br
an
e
25
×
25
m
m
24
%
bo
ne
ga
in
w
it
h
m
em
br
an
e&
19
%
w
it
ho
ut
R
es
id
ua
l
bo
ne
19
%
(w
it
ho
ut
m
em
br
an
e:
7.
8
±
1.
9
m
m
;w
it
h
m
em
br
an
e:
7.
2
±
1.
5
m
m
;m
ea
n
±
SD
).
H
ig
h
re
so
lu
ti
on
m
ic
ro
C
T
m
m
R
.C
.T
C
an
ul
lo
L
et
al
.
[3
2]
16
- -
1–
3
m
m
na
no
cr
ys
ta
lli
ne
hy
dr
ox
ya
pa
ti
te
si
lic
a
ge
l
6
m
on
th
s
48
±
4.
63
%
ne
w
ly
fo
rm
ed
bo
ne
28
±
5.
33
%
,r
es
id
ua
l
m
at
er
ia
l
A
liz
ar
in
re
d
st
ai
n
us
in
g
Im
ag
e
J
so
ft
w
ar
e
Si
gn
al
In
te
ns
it
y
Su
sa
nn
a
A
nn
ib
al
i
et
al
.,
20
14
[3
3]
4
pa
ti
en
ts
3
1
m
ea
n
ag
e
52
ye
ar
s,
ra
ng
e
36
–7
0
A
tr
op
hi
ed
m
ax
ill
a
Le
ss
th
an
3
m
m
(H
A
-..
-T
C
P
30
/7
0)
,
an
or
ga
ni
c
bo
vi
ne
bo
ne
(A
BB
),
m
in
er
al
iz
ed
so
lv
en
t-
de
hy
dr
at
ed
bo
ne
al
lo
gr
af
t
(M
SD
BA
),
an
d
eq
ui
ne
bo
ne
(E
B)
,
A
ft
er
6
m
on
th
s
30
.2
%
ne
w
ly
fo
rm
ed
bo
ne
fo
r
H
a-
.-T
C
P
30
/
70
,2
0.
1%
fo
r
A
BB
,1
6.
4%
fo
r
M
SD
BA
,
an
d
21
.9
%
fo
r
EB
.R
es
id
ua
l
m
at
er
ia
l
(H
A
-..
-T
C
P-
30
/7
0)
.
29
.1
%
,(
A
BB
).
19
.1
%
,(
M
SD
BA
)
18
.5
%
,(
EB
)2
3.
2%
.
co
m
pu
te
ri
ze
d
to
m
og
ra
ph
y
(C
T)
SC
A
N
H
.U
To
ul
di
ne
bl
ue
R
.C
.T
C
la
ud
io
St
ac
ch
i
et
al
.[
34
]
28
pa
ti
en
ts
18
10
3–
6m
m
N
an
oh
yd
ro
xy
ap
at
it
e,
an
or
ga
ni
c
bo
vi
ne
bo
ne
6
m
on
th
s
N
ew
ly
fo
rm
ed
bo
ne
34
.9
±
15
%
(N
H
A
)
38
.5
±
17
%
(A
BB
)
an
d
re
si
du
al
gr
af
t
20
.6
±
13
%
(N
H
A
)
22
.3
±
12
%
(A
BB
)
C
.B
.C
.T
.H
U
To
ul
od
in
e
bl
ue
R
.C
.T
A.K. Abo zekry et al. Future Dental Journal 4 (2018) 135–140
139 139
Abozekrya et al.: Open sinus lift surgery and augmentation with (SCPC versus H.A):
Published by Arab Journals Platform, 2018
5. Conclusion
For the clinical point of view the present systematic review sup-
ported the fact that open sinus lift with grafting with bone substitute act
as scaffold for a new bone formation leading to formation of new bone
but we need further research on different types of bone grafts to im-
prove its character and to improve the nature of the newly formed bone.
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